Connect with us

Latest News

U.S. Connected Care Market Is Expected To Grow At A CAGR Of 16% During The Forecast Period 2019–2025

Published

on

The U.S. connected care market by revenue is expected to grow at a CAGR of over 16% during the period 2019–2025. Connected care is bringing patient and clinical management together in the realm of care continuum by linking caregivers, payers, physicians to patients from across clinics, hospitals, and homes. It is driving the development of care through proven clinical care pathways and better workflows. The growing enthusiasm for telehealth has seen a lot of interest and investments from major health companies. From tele-neonatology programs to virtual hospitals, all systems have prompted the transition to digital health. Further, the COVID-19 pandemic has driven new realities in the healthcare industry of interoperability and agility. The need for remote collaborations in healthcare facilities and patients has given connected care a faster momentum. The market growth is rooted in telehealth and is largely known to constitute RPM and telehealth. However, the trend of virtual medicine increasingly streaming video, patient data and test results straight to clinicians has opened up new frontiers.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-91154

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Prominent Vendors

• Koninklijke Philips
• ResMed
• Boston Scientific
• Medtronic
• Connect America

INSIGHTS BY VENDORS

The U.S. connected care market is moderately fragmented. New entrants are offering new solutions with new technologies such as IoT, AI, and predictive analytics. Players are expected to witness a more competitive and challenging atmosphere due to the increased new regulatory pressure, legal scrutiny and due to the forces of new, innovative players in the healthcare space. The market competition is expected to play out in one or more ways. Technology and MedTech players could differentiate their offerings and occupy exclusive areas in the market; provide fragmented service and product offerings; bring everything within the company by creating an in-house data platform that can connect to several devices; offer advanced predictive diagnosis and user-friendly devices but keep the health-based data within the MedTech ecosystem.

The following factors are likely to contribute to the growth of the U.S. connected care market during the forecast period:

• Artificial Intelligence transforming healthcare
• Less Invasive, More Invisible
• BYOD and Wearables Gain Momentum
• Reconfiguration of the Healthcare System due to COVID-19

U.S. CONNECTED CARE MARKET SEGMENTATION

The U.S. connected care market research report includes a detailed segmentation by type, component, end-user, and geography. The RPM segment is witnessing growth on account of better clinical and patient experience, lower costs, and improved outcomes. In 2019, several clients carried out pilot RPM programs, which they expanded swiftly in 2020, are driving the demand for specialized monitoring systems. Simplifying Bluetooth technology is expected to be crucial for mainstreaming the adoption of RPM technology. Further, tablets and smartphones are coming to the front as they can be linked to healthcare wearables and telehealth video conferencing and allow for the implementation of electronic health record-based patient portals.

The medical alert systems market has significantly grown and changed recently. The shortage of healthcare workforce and the limitations in long-term services and supports (LTSS) formal care systems are leading to increased demand for PERS systems. A majority of clinicians, home and healthcare professionals, and case managers are advocating the use of these devices among the elderly, driving volume growth. The market has made a shift from landline to mobile PERS over the last half of the decade as consumers are increasingly getting rid of landline phones.

The software and services segment has been witnessing significant progress in the recent past owing to heightened acceptance for connected care and increased demand for better data collection. Connected devices collect data, analyze, and display them and analyze self-reported data from patients. The software and services segment is expected to reach over $20 billion by 2025. The regulatory environment is showing signs of favorability, making it easy for players to navigate the market and roll out new solutions. However, the low ability of transference of technology across several therapy areas is a major challenge, which is reducing implementation.

The acceptance for homecare setting is growing. A growing number of organizations, which are debuting and scaling models to move acute, primary, and palliative care to the home, is driving the segment growth. As healthcare is increasingly shifting into homes owing to population health efforts and demand for personalized healthcare, medical devices are being designed to be used within the setting. Players in the market are working on making devices automatic and invisible in terms of design that they can integrate seamlessly into consumers’ lives, thereby increasing the demand.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-91154

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

The growth of virtual hospitals on account of the development of IoT is driving the demand for onsite connected care solutions. The rise of dedicated patient portals, which are putting power in the hand of patients to take more control by both gaining access to and feeding in their health information and images. The U.S. connected care market shares is expected to observe growth opportunities by going beyond traditional patient care and expanding into therapy, combining with RPM platforms to monitor the patient’s progress.

Table of Content

1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segment
4.4.1 Market Segmentation by Type
4.4.2 Market Segmentation by Component
4.4.3 Market Segmentation by End-use
4.4.4 Market Segmentation by Delivery
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

The study considers the present scenario of the U.S. connected care market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Key Questions Answered

1. What is the U.S. connected care market size and growth rate during the forecast period?
2. What are the factors impacting the growth of the U.S. connected care market shares?
3. How is the growth of the hospitals & clinics segment influencing the growth of the U.S. connected care market?
4. Who are the leading vendors in the U.S. connected care market, and what are their market shares?
5. What is the impact of the COVID-19 pandemic on the U.S. connected care market?

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Reports:

Albania: Living and Dining Room Furniture Market
Austria: Living and Dining Room Furniture Market
Belgium: Living and Dining Room Furniture Market 
Bosnia and Herzegovina: Living and Dining Room Furniture Market
Chile: Chairs and Sofas Market 
Colombia: Chairs and Sofas Market
Costa Rica: Chairs and Sofas Market
Cuba: Chairs and Sofas Market 
Dominican Republic: Chairs and Sofas Market
Ecuador: Chairs and Sofas Market
El Salvador: Chairs and Sofas Market
Guatemala: Chairs and Sofas Market

Continue Reading
Comments

Latest News

The Global Market for Anti-Corrosion Nanocoatings: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast 2020-2030

Published

on

Corrosion in its various forms is estimated to cost the global economy $3 trillion a year. The current world market size for anti-corrosion coatings is over $12 billion. With increased demand from energy and mining resources the market growth is estimated to be around 4.5% per annum.

Growth in nanocoatings will be above the CAGR due to their ability to provide excellent chemical and abrasion resistance with excellent adhesion and meet regulatory requirements. The majority of current product in anticorrosion coatings is directed towards meeting these stringent environmental standards dealing with emissions of volatile organic compounds (VOCs), especially in North America and Europe. Main growth markets are in water filtration and treatment, oil and gas pipeline coatings and wind turbine coatings.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-106054

There is a market need for a cost-effective non-epoxy-based corrosion resistant coating operable in environments of temperature swings, strong acid, water, and/or road salt. Nanoparticle materials have a very high surface area. When this surface is functionalized, it can deliver high loadings of organic corrosion inhibitors. Thus, tailored nanoparticles are the ideal carrier for delivery of the needed level of active corrosion inhibitors.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Blood Glucose Monitors Market 

Biosimilars Market 

Bioabsorbable Stents Market 

Nonalcoholic steatotic hepatitis (NASH) Market 

Anxiety Disorders Treatment Market 

Cholera Vaccines Market 

Animal Health Market

Continue Reading

Latest News

Global Market for Self-Cleaning Coatings: Global Industry, Trends, Market Size, Forecast up to 2030

Published

on

A more recent version of this report is now available, The Global Market for Self-Cleaning Coatings 2020

Self-cleaning coatings are completely transparent and allow for surfaces that are clean, stain resistant and dry, mainly for application on on glass in buildings, solar panels and cars. They can also be used as a waterproof protection for wood, masonry and tarpaulin.

Clean or self-cleaning surfaces can be achieved by two principally different approaches. A photocatalytic coating can be applied to the surface, where the effect of the sun’s ultraviolet rays catalytically breaks down organic dirt. At the same time the surface changes into a superhydrophilic at which time the water spreads evenly over the surface and less drying traces are formed by dripping.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-106044

Another way to manufacture a self-cleaning (bionic) surface in which the surface becomes a super-hydrophobic. Superhydrophobic coatings and films have a wide spectrum of applications; they are used not only for resisting water and fog condensation, but also for preventing contamination.

Report contents include:

Evolution of self-cleaning coatings to now and future prospects.
Development of autonomic and more durable self-cleaning coatings.
Analysis of hydrophobic and hydrophilic surfaces and the emergence of super-hydrophobic and super-hydrophilic coatings technologies.
New developments in self-cleaning coatings including mutli-functional and smart self-cleaning coatings.
Applications and market analysis for self -cleaning coating in Construction, Automotive, Solar, Textiles and Apparel, Consumer Electronics, Medical Coatings, Marine and Household Care sectors.
Revenue forecasts to 2027 across all sectors.
146 company profiles including products and target markets.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Varicose Veins Treatment Devices Market 

Vitamin D Testing Market 

Healthcare Cognitive Computing Market 

Smart Medical Devices Market 

Legal Marijuana Market 

Pharmacovigilance market 

Cancer Therapeutics Market 

Continue Reading

Latest News

The Global Market for Abrasion and Wear Resistant Nanocoatings

Published

on

The surface hardness and the wear resistance of materials can be significantly improved through the use of nanocoatings. The incorporation of nanomaterials improves wear resistance and toughness properties and offers comprehensive corrosion inhibition, as well as meeting stringent regulatory and safety requirements.

There are already numerous commercial applications in mechanical structures and in the machining of materials. The emphasis is on metal treatment, but also promising results have been shown for non-metallic materials. Applications include:

Automotive: Vehicle and protective environments; Scratch-resistant varnishes for automobile paint.
Light metals and various kinds of steel, such as technical parts for cars and aircrafts as well as engine parts.
Food processing
Interior and exterior protection: Mar and scratch resistant coatings for furniture and parquet; Scratch resistant high gloss lacquers on wood and barrier coatings on plastics.
Electronics: Protective layers for semiconductor chips; Transparent plastics such as acrylic glass (PMMA), SAN and polycarbonate, e.g. for plastic walls or displays of mobile phones.
Scratch proof coatings for optical components.
The Global Market for Abrasion and Wear Resistant Nanocoatings Report includes:

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-106045

Market revenues for abrasion and wear resistant nanocoatings.
Detailed analysis of the benefits of using abrasion and wear resistant nanocoatings.
Current products.
53 Abrasion and Wear Resistant Nanocoatings producer profiles.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Liver Cancer Diagnostic Market 

Irritable Bowel Syndrome (IBS) Treatment Market 

Livestock Monitoring Market 

Ligation Devices Market 

Insulin Patch Pumps Market 

Liver Cancer Drugs Market 

Augmented Reality (AR) and Virtual Reality (VR) Market 

In-vitro Toxicology Testing Market 

Kidney Cancer Market 

Internet of Things In Healthcare Market 

Influenza Diagnostics Market 

Immunohistochemistry Market 

Injection Pen Market 

Lysosomal Acid Liapse (LAL) Deficiency Treatment Market 

Liquid Biopsy Market 

Hybrid Imaging Market 

Continue Reading

Latest News

Hormone Replacement Therapy (HRT) Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast 2020-2030

Published

on

The Hormone Replacement Therapy (HRT) market is estimated to represent a global market of USD 20.97 billion by 2019 with growth rate of 7.5%.

Market Dynamics

Menopause is a natural and inevitable event, defined as the final menstrual period. It requires a retrospective clinical diagnosis with ethnic and regional variations. Hormone replacement therapies (HRT) such as systemic estrogen (skin patch, gel, or cream) are considered to be the most effective treatment option in the treatment of menopausal night sweats and hot flashes. These therapies also ease vaginal symptoms of menopause such as itching, burning, and dryness. Due to this fact, women undergoing these therapies has increased considerably over the past few years.

As per the Rose Research Survey (April 2014), women accepting HT therapy has increased considerably, from 4.5 million in 2005 to around 5.0 million in 2014. In addition to this, the growth of this market is attributed to the rise in a number of women in menopausal age coupled with growing patient awareness. For example, according to the International Menopause Society, thousands of women reach menopause experience every day. On another hand, the high cost of therapies coupled with the high risk of adverse reactions posing a potential threat to this industry. For example, as per the study published in PLOS One journal in 2014, testosterone therapy in cardiac patients considerably increase the risk of heart attack.

Replacement Therapy Takeaway

In terms of replacement therapy, the market is categorized as Estrogen, Human Growth Hormone, Testosterone and Thyroid. Estrogen replacement therapy recorded USD 9.58 billion and is expected to soar owing to the approval of new products by the United States Food and Drug Association under this category. Some of the recommended estrogen doses for women with Primary Ovarian Insufficiency (POI) are 1.25 mg conjugated equine estrogen (CEE), 17b-estradiol 2 mg/day, and transdermal estradiol 75–100 mg/day.

Furthermore, Climara, Estradot, Divigel, Elestrin, and EstroGel are some of the commercially available transdermal estrogen products in the U.S. and Canada market by various manufacturers. On contrary, thyroid replacement therapy is considered to be the lowest revenue generating segment and is also pegged to register slowest growth rate i.e. 6.9% in terms of value. Levothyroxine (generic form of thyroxine) is a most commonly prescribed thyroid hormone replacement drug across the globe.

Cumulative effect of COVID-19

As players move from reacting to mitigating the impact of the COVID-19 outbreak, they are keenly focusing on Hormone Replacement Therapy (HRT) market offers detailed analysis on the emerging market player during this outbreak. The report also included the detailed study related to impact of COVID-19 on the supply chain based on both downstream and upstream markets. The report also includes the future development in the Hormone Replacement Therapy (HRT) Market in relation with the market impact of COVID-19.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-53287

Regional Takeaway

Regionally, the market is divided into North AmericaEuropeAsia Pacific and Rest of the World. Of these, North America captured the highest share, 41.67% of the total market. Drugs such as Premarin, AndroGel, and Levothyroxine have been recorded to gain the maximum prescription within this region. However, Asia Pacific region represents one of the fastest growing regions, enjoying an annual average growth rate over 9.0%. Rising awareness levels coupled with increasing focus of healthcare and government on eradication of hormonal deficiencies are likely to establish a healthy platform for the industry growth in this region.

Key Vendor Takeaway

Companies such as Novo Nordisk, Amgen, Inc., Abbott, Eli Lily and Genentech are covered under research study. The industry experiences a high level of competition. In such fragmented landscape, key players are actively engaged in strategic collaborations to expand their market presence. For instance, in February 2015, Mylan Laboratories signed an agreement for the acquisition of Famy Care.

This acquisition has helped the company to increase its female health product portfolio inclusive of production of hormone replacement drugs, Intra-Uterine Devices (IUD), and contraceptives. Likewise, in December 2014, Pfizer collaborated with OPKO Health. As per the agreement, OPKO would be developing and marketing long-acting human growth hormone (hGH-CTP) (PF-06836922), whereas Pfizer would take care of the post-market studies and development costs.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 Impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
 

SCOPE OF THE REPORT


The scope of this report covers the market by its major segments, which include as follows:

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY REPLACEMENT THERAPY
Estrogen
Human Growth Hormone
Testosterone
Thyroid

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY ROUTE OF ADMINISTRATION
Parenteral
Oral
Transdermal
Other

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY DISEASE
Male Hypogonadism
Menopause
Hypothyroidism
Growth Hormone Deficiency
Others

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Enteral Feeding Devices Market 

Dental Equipment Market 

Intravenous Solutions Market 

Fertilization Technique Market 

Artificial Insemination Market 

Medical Oxygen Concentrators Market 

Assisted Reproductive Technology (ART) Market 

Tuberculosis Drugs Market 

STD Diagnostics Market 

Stethoscope Market 

Thalassemia Market 

U.S. Pharmacy Benefit Management (PBM) Market 

Magnetic Resonance Imaging Market 

Infectious Diseases In Vitro Diagnostics Market 

Inflammatory Bowel Disease (IBD) Treatment Market 

Infection Surveillance Solutions Market 

Continue Reading

Latest News

Hemophilia Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast 2020-2030

Published

on

The hemophilia market is estimated to represent a global market of USD 11.62 billion by 2019 with growth rate of 5.3%.

Market Dynamics

Over the eight years to 2016, revenue for the hemophilia industry is anticipated trend higher. Increasing neonatal population is expected to drive the hemophilia diagnosis demand globally. The World Population Meter stated that more than 88.0 billion newborns were reported in 2015 resulting in about 250 births per minute. Of which, approximately 2.8 million infants died within the first month, due to lack of skilled care and proper screening of the babies. The World Health Organization (WHO) also stated that around 2.6 million children died in their first month of life across the globe, which is 7,000 newborn deaths every day. In addition, strong product pipeline will further stimulate the industry growth to great extent over the future period. For example, N9-GP, Concizumab, N8-GP, and Recombinant factor VIIa are some of the bleeding disorder therapeutics under clinical investigations by Novo Nordisk. Despite the industry pipeline increasing, some potential threats exist which will likely to hinder growth prospects going forward. Factors such as high treatment cost coupled with low acceptance of advanced technologies are posing a potential threat to the market.

Types Takeaway

In terms of types, the market is categorized into A, B, C, and other types. Type A accounted for the highest share of the total market. In 2019, the segment recorded 6.8 billion and is expected to dominate the global market over the forecast period. This type is acquired due to the deficiency of clotting factor VIII, which is an anti-hemophilic factor (AHF). According to the National Hemophilia Foundation (NHF), 1 in 5,000 male population affect with type A disorder, which makes it four times more common compared to the type B. As per the Hemophilia News Today, around 4,000 to 5,000 males are affected with type A disease worldwide. Markets besides hemophilia A, B & C is expected to generate the remaining 5.0% of market revenue in 2019.

COVID 19 Impact on hemophilia market
As key companies move from reacting to mitigating the impact of the COVID-19 outbreak, they are keenly focusing on strategies that may result in emerging as strong market player. The published research included the detailed study related to the COVID-19 Impact on the supply chain based on both downstream and upstream markets. The proposed report also includes the future development in the hemophilia Market in relation with the impact of COVID-19 on the market.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-53288

Key Vendor Takeaway

Companies namely, Novo Nordisk, Bayer AG, Pfizer, Inc., Baxalta, and Biogen are profiled. In light of more players entering in this market. the degree of competition has intensified over a couple of years. Competition is based on the development of new therapeutics and co-pay programs.

For example, Grifols provide co-pay programs such as ALPHANATE Copay Program and AlphaNine SD Copay card for this bleeding disorder treatment with an unlimited monetary limit. In addition, companies are engaged in donation activities with government organizations. For instance, in 2016, the World Federation of Hemophilia collected 1.5 million units of anti-hemophilic agents from CSL Behring as a donation on World Hemophilia Day.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 Impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

HEMOPHILIA MARKET, BY TYPES

Hemophilia A
Hemophilia B
Hemophilia C
Others

HEMOPHILIA MARKET, BY TREATMENT
On-demand
Prophylaxis

HEMOPHILIA MARKET, BY THERAPY
Immune Tolerance Induction (ITI) therapy
Replacement therapy
Gene therapy

HEMOPHILIA MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Aerosol Actuator Market 

Acetic acid Market 

Di Methyl Ether Market 

Laboratory Informatics Market 

Connected Health & Wellness Devices Market 

Specialty Generic Pharmaceuticals Market 

Asthma Therapeutics Market 

Antifungal Drugs Market 

Fluorescent In Situ Hybridization Probe (FISH Probe) Market 

Bone Densitometer Market 

Capnography Device market 

Genitourinary Therapeutics Market 

Monoclonal Antibodies Market 

Oxygen Therapy Market Pain Management Devices Market

Continue Reading

Trending